TABLE 2.
Prevalence of recrudescent infections with >1% of parasites carrying an additional mutation compared to the infecting parasite and with treatment administered 8 days after the start of asexual infection
| DHFR/DHPS genotype of infecting parasite | % of simulations with >1% of recrudescent parasites carrying an extra mutation
|
||
|---|---|---|---|
| Three tablets achieving 100% of expected concn | Three tablets achieving 80% of expected concn | Two tablets achieving 100% of expected concn | |
| 1M/3M | 0.0a | 0.0a | 0.5a,b |
| 2M/WT | 0.0 | 0.3b | 1.7 |
| 2M/1M | 1.5 | 2.6 | 4.0 |
| 2M/2M | 2.6 | 6.5 | 15.6 |
| 2M/3M | 10.2a | 18.6a | 20.9a |
Additional mutations can only occur in the DHFR gene.
All infections that recrudesced had >1% of parasites carrying an additional mutation compared to the infecting parasite.